Press Releases (Page 73)
EVOLV ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Evolv Technologies Holdings, Inc. and Encourages Investors to Contact the Firm
NEW YORK, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Evolv Technologies Holdings, Inc. (“Evolv” or the “Company”) (NASDAQ: EVLV) in the United States District Court for the District of Massachusetts on behalf of all persons and entities who purchased or otherwise acquired Evolv securities between... ❯❯❯
Wolf Popper LLP Announces Investigation on Behalf of PACS Group, Inc. Investors
NEW YORK, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Wolf Popper LLP is investigating potential claims on behalf of purchasers of PACS Group, Inc. (“PACS”) common stock (NYSE: PACS). PACS operates skilled nursing and assisted living facilities. PACS had its IPO April 10, 2024 and sold 24.6 million shares at $21.00 per share. On September 5, 2024, PACS and its two co-founders sold 19.0 million shares at $36.25 per share in a secondary... ❯❯❯
ELAN LAWSUIT ALERT: A Securities Fraud Class Action has been filed against Elanco Animal Health; Investors are Urged to Contact the Firm by December 6 (NYSE:ELAN)
NEW YORK, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elanco Animal Health Incorporated (NYSE:ELAN) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Elanco, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elanc... ❯❯❯
BFA Law is Investigating ADMA BIOLOGICS for Securities Fraud after Stock Plummets 20%; Contact the Firm if You Suffered Losses (Nasdaq:ADMA)
NEW YORK, Nov. 02, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ: ADMA) for potential violations of the federal securities laws. If you invested in ADMA Biologics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/adma-biologics-inc. Why Did ADMA Biologics’s Stock Drop? ADMA... ❯❯❯
IRHYTHM ALERT: Bragar Eagel & Squire, P.C. is Investigating iRhythm Technologies, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against iRhythm Technologies, Inc. (NASDAQ: IRTC) on behalf of long-term stockholders following a class action complaint that was filed against iRhythm on February 6, 2024 with a Class Period from January 11, 2022, to May 30, 2023. Our investigation concerns whether the board... ❯❯❯
MYNARIC ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Mynaric AG and Encourages Investors to Contact the Firm
NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Mynaric AG (“Mynaric” or the “Company”) (NASDAQ:MYNA) in the United States District Court for the Eastern District of New York on behalf of all persons and entities who purchased or otherwise acquired Mynaric securities between June 20, 2024 and... ❯❯❯
COMPASS MINERALS ALERT: Bragar Eagel & Squire, P.C. is Investigating Compass Minerals International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Compass Minerals International, Inc. (NYSE: CMP) on behalf of long-term stockholders following a class action complaint that was filed against Compass Minerals on April 24, 2024 with a Class Period from November 29, 2023 to March 22, 2024. Our investigation concerns... ❯❯❯
ELAN CLASS ACTION: Elanco Animal Health Investors with Losses are Notified of Ongoing Class Action; Contact BFA Law before December 6 Legal Deadline (NYSE:ELAN)
NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elanco Animal Health Incorporated (NYSE:ELAN) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Elanco, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/ela... ❯❯❯
ADMA INVESTIGATION: ADMA Biologics Investors with Losses are Notified to Contact BFA Law about Ongoing Securities Fraud Investigation into Auditor Resignation (Nasdaq:ADMA)
NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ: ADMA) for potential violations of the federal securities laws. If you invested in ADMA Biologics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/adma-biologics-inc. Why Did ADMA Biologics’s Stock Drop? ADMA... ❯❯❯
EW CLASS ACTION: Edwards Lifesciences Investors with Losses are Notified of Ongoing Class Action; Contact BFA Law before December 13 Legal Deadline (NYSE:EW)
NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investi... ❯❯❯